237 filings
8-K
JAZZ
Jazz Pharmaceuticals plc
28 Feb 24
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results
4:06pm
8-K
JAZZ
Jazz Pharmaceuticals plc
27 Feb 24
Departure of Directors or Certain Officers
7:45am
8-K
JAZZ
Jazz Pharmaceuticals plc
21 Feb 24
Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
7:46am
8-K
JAZZ
Jazz Pharmaceuticals plc
25 Jan 24
Entry into a Material Definitive Agreement
5:01pm
8-K
JAZZ
Jazz Pharmaceuticals plc
8 Jan 24
Results of Operations and Financial Condition
7:45am
8-K
8m6tae
15 Dec 23
Departure of Directors or Certain Officers
7:45am
8-K
626a3p
8 Nov 23
Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:07pm
8-K
verh 5o0vi
12 Sep 23
Departure of Directors or Certain Officers
7:36am
8-K
9pxxrcuz 22dlix8
9 Aug 23
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
4:07pm
8-K
mh8o9t6rruu508sc5
22 Jun 23
Regulation FD Disclosure
4:05pm
8-K
lrvux9mq a9jprj
10 May 23
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
4:08pm
8-K
9szzspq7hzkbe 4tko
1 Mar 23
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance
4:07pm
8-K
jvaa6czcbikticlnp
9 Jan 23
Results of Operations and Financial Condition
7:31am
8-K
nkya3 qpsaoe84gkirgq
4 Jan 23
Other Events
5:25pm
8-K
8as62ow8dyflyb
21 Dec 22
Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab
7:40am
8-K
gexjzqcd5v6gxnhkqt
5 Dec 22
Completion of Acquisition or Disposition of Assets
4:16pm
8-K
woh c2482cy
14 Nov 22
Other Events
4:31pm
8-K
6qi8l6
9 Nov 22
Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point
4:07pm
8-K
kjd13151 bi02
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:59am
8-K
109fgz 25ug7x
3 Aug 22
Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance
4:07pm